BiomX, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders Equity (Details)

Stockholders Equity (Details) - USD ($) $ / shares in Units, $ in Thousands							1 Months Ended	9 Months Ended
	May 04, 2023	Mar. 01, 2023	Feb. 27, 2023	Feb. 22, 2023	Dec. 31, 2021	Dec. 31, 2020	Aug. 21, 2023	Sep. 30, 2023	Sep. 30, 2022	Apr. 24, 2023	Dec. 31, 2022	Nov. 30, 2017
Stockholders Equity (Details) [Line Items]
Share issued (in Shares)				15,997,448						24,632,243
Shares issued price per share (in Dollars per share)				$ 0.245	$ 2.57
Gross proceeds				$ 7,485
Exercise price per share (in Dollars per share)			$ 0.001
Net proceeds			$ 1,293
Issuance cost			$ 176
Common stock shares issued (in Shares)	12,797,957
Exercisable price per share (in Dollars per share)	$ 0.001
Offering price amount						$ 19,950
Average price per share (in Dollars per share)									$ 1.19
Aaggregate net proceeds									$ 273
Aggregate commission amount									$ 8
Amount receivable					$ 5,000
Equity method of investment					3,000
Additional received amount					2,000
Aggregate amount					$ 2,000
Preferred stock, shares authorized (in Shares)								1,000,000			1,000,000
Preferred stock, par value (in Dollars per share)								$ 0.0001			$ 0.0001
Granted option shares (in Shares)		1,543,000					82,000
Exercise price (in Dollars per share)								$ 0.001
Vesting period term								1 year
Fair value of grant date								$ 510
Second Tranche [Member]
Stockholders Equity (Details) [Line Items]
Shares issued price per share (in Dollars per share)					$ 2.57
Pre funded warrants [Member]
Stockholders Equity (Details) [Line Items]
Pre-funded warrants (in Shares)				14,610,714
Shares issued price per share (in Dollars per share)				$ 0.244
Net proceeds	$ 5,859
Issuance cost	$ 157
Warrant [Member]
Stockholders Equity (Details) [Line Items]
Share issued (in Shares)			3,199,491
Pre-funded warrants (in Shares)	11,834,286		2,776,428
Gross proceeds			$ 1,469
Exercise price (in Dollars per share)
Number of shares of common stock underlying warrants (in Shares)								2,974
Preferred Stock [Member]
Stockholders Equity (Details) [Line Items]
Preferred stock, shares authorized (in Shares)								1,000,000
Founder [Member]
Stockholders Equity (Details) [Line Items]
Number of shares of common stock underlying warrants (in Shares)												2,974
Pre funded warrants [Member] \| Minimum [Member]
Stockholders Equity (Details) [Line Items]
Percentage of ownership								9.90%
Pre funded warrants [Member] \| Maximum [Member]
Stockholders Equity (Details) [Line Items]
Percentage of ownership								9.99%
Stock Options [Member]
Stockholders Equity (Details) [Line Items]
Exercise price (in Dollars per share)							$ 0.363
Board of Directors [Member]
Stockholders Equity (Details) [Line Items]
Exercise price (in Dollars per share)		$ 0.4
Vesting period term		4 years					4 years
Equity Method Investment [Member]
Stockholders Equity (Details) [Line Items]
Equity method of investment					$ 2,000